No Sodium Oxybate for Fibromyalgia
Links shared publicly online about this topic
Sodium Oxybate for Fibromyalgia: Data are Promising
chronicfatigue.about.com — “Sodium Oxybate for Fibromyalgia: Data are Promising” View full resource at chronicfatigue.about.com
Most Recently Shared on June 18, 2009 at 8:36 pm By:
Sodium Oxybate for Fibromyalgia: Data are Promising - About - News & Issues http://tinyurl.com/mzhehz
Sodium Oxybate for Fibromyalgia: New Results Released
chronicfatigue.about.com — “Sodium Oxybate for Fibromyalgia: New Results Released” View full resource at chronicfatigue.about.com
Most Recently Shared on June 25, 2009 at 8:40 pm By:
Sodium Oxybate for Fibromyalgia: New Results Released http://tinyurl.com/kt2zwy
Sodium Oxybate Reduces Fibromyalgia Pain and Fatigue
medworm.com — “: Sodium oxybate, an investigational metabolite of gamma-aminobutyric acid, targets deep sleep disturbances common in fibromyalgia patients, reducing fatigue and pain.” View full resource at medworm.com
Most Recently Shared on October 29, 2009 at 4:23 am By:
Sodium Oxybate Reduces Fibromyalgia Pain and Fatigue http://bit.ly/1QcRC
FDA Panel Says No to Sodium Oxybate for Fibromyalgia - QualityPoint Technologies
qualitypointtech.net — “A joint FDA advisory committee has voted against approval of sodium oxybate for fibromyalgia. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on August 23, 2010 at 12:36 pm By:
FDA Panel Says No to Sodium Oxybate for Fibromyalgia: A joint FDA advisory committee has voted against approval of... http://bit.ly/cyQMki
Sodium Oxybate for Fibromyalgia Does Well in First International Trial
medworm.com — “: A placebo-controlled study of sodium oxybate resulted in a clinically relevant reduction in pain of more than 30% and significant improvements in quality of life and sleep.” View full resource at medworm.com
Most Recently Shared on February 13, 2010 at 4:45 am By:
Sodium Oxybate for Fibromyalgia Does Well in First International Phase 3 Trial http://bit.ly/aKJcus
Second Phase 3 study of sodium oxybate for fibromyalgia pain - MPR
empr.com — “Jazz Pharmaceuticals and UCB announced positive preliminary top-line results from the second of two Phase 3 clinical trials of sodium oxybate (JZP-6) for the treatment of fibromyalgia.” View full resource at empr.com
Most Recently Shared on June 25, 2009 at 6:40 pm By:
MPR News: Second Phase 3 study of sodium oxybate for fibromyalgia pain: Jazz Pharmaceuticals and UCB an.. http://tinyurl.com/nlhxsd
Jazz Pharmaceuticals Provides Update On FDA Advisory Committee Meeting For JZP-6 (Sodium Oxybate) In Fibromyalgia
medicalnewstoday.com — “Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced that the Joint Advisory Committee of the U.S. Food and Drug Administration (FDA), including the Arthritis Advisory Committee and the Drug Safet” View full resource at medicalnewstoday.com
Most Recently Shared on August 24, 2010 at 12:30 pm By:
MNT Arthritis News Health News
Jazz Pharmaceuticals Provides Update On FDA Advisory Committee Meeting For JZP-6 (Sodium Oxybate) In Fibromyalgia http://mnt.to/3HLz
Therapy: Sodium oxybate for fibromyalgia. [Nat Rev Rheumatol. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on June 4, 2011 at 10:51 am By:
FibroAction Health Organization
On Pubmed: Therapy: Sodium oxybate for fibromyalgia.: Therapy: Sodium oxybate for fib... http://tinyurl.com/3llwkb2 #fibro #fibromyalgia
Jazz Pharmaceuticals Provides Update on FDA Advisory Committee Meeting For JZP-6 (Sodium Oxybate) in Fibromyalgia - Health News - redOrbit
redorbit.com — “PALO ALTO, Calif., Aug. 20 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that the Joint Advisory Committee of the U.S.” View full resource at redorbit.com
Most Recently Shared on August 21, 2010 at 5:04 am By:
Jazz Pharmaceuticals Provides Update on FDA Advisory Committee Meeting For JZP-6 (Sodium Oxybate) in Fibromyalgia:... http://bit.ly/bN9MRG
Sodium Oxybate & Sleep in Fibromyalgia
chronicfatigue.about.com — “Sodium Oxybate & Sleep in Fibromyalgia” View full resource at chronicfatigue.about.com
Most Recently Shared on August 9, 2010 at 9:14 pm By:
Sodium Oxybate & Sleep in Fibromyalgia http://bit.ly/aq42UK
Sodium oxybate improves symptoms of fibromyalgia - JAAPA
jaapa.com — “Clinical question: Does sodium oxybate improve symptoms in patients with fibromyalgia?” View full resource at jaapa.com
Most Recently Shared on January 28, 2010 at 5:43 am By:
Sodium oxybate improves symptoms of fibromyalgia - Journal of the American Academy of Physician Assistants http://tinyurl.com/cmbssh
Data Suggest Sodium Oxybate Significantly Improves Pain And The Core Symptoms Of Fibromyalgia
medicalnewstoday.com — “Jazz pharmaceuticals' (nasdaq: jazz) sodium oxybate (jzp-6) demonstrated statistically significant and clinically meaningful improvement in pain and the core symptoms associated with fibromyalgia” View full resource at medicalnewstoday.com
Most Recently Shared on June 18, 2009 at 12:42 am By:
Data Suggest Sodium Oxybate Significantly Improves Pain And The Core Symptoms Of Fibromyalgia http://tinyurl.com/lec75f
Jazz Pharmaceuticals/UCB's Sodium Oxybate Will Account for More Than 15 Percent of the Fibromyalgia Drug... -- WALTHAM, Mass., Jan. 18 /PRNewswire/ --
prnewswire.com — “Jazz Pharmaceuticals/UCB's Sodium Oxybate Will Account for More Than 15 Percent of the Fibromyalgia Drug Market in 2018. However, Sodium Oxybate's Uptake Will be Substantially Limited by Factors That Include the Risk of Severe Adverse Events and Potential for Abuse and Illicit Use, According to New Findings from Decision Resources.” View full resource at prnewswire.com
Most Recently Shared on January 18, 2010 at 1:54 pm By:
Jazz Pharmaceuticals/UCB's Sodium Oxybate Will Account for More Than 15 ... - PR Newswire (press release) http://bit.ly/6r3SV9
Data from Jazz Pharmaceuticals' First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences | Reuters
reuters.com — “Data from Jazz Pharmaceuticals' First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences PALO ALTO, Calif., Oct. 14 /PRNewswire-FirstCall/ -- Jazz” View full resource at reuters.com
Most Recently Shared on October 15, 2009 at 3:29 am By:
Data from Jazz Pharmaceuticals' First Phase III Study of Sodium Oxybate in ... - Reuters http://bit.ly/7lC3z
Jazz Pharmaceuticals Submits New Drug Application For JZP-6 (sodium Oxybate) For The Treatment Of Fibromyalgia
medicalnewstoday.com — “Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for JZP-6 (sodium oxybate oral solution) for the treatmen” View full resource at medicalnewstoday.com
Most Recently Shared on December 16, 2009 at 11:17 am By:
MNT Clinical Trials Health News
Jazz Pharmaceuticals Submits New Drug Application For JZP-6 (sodium Oxybate) For The Treatment Of Fibromyalgia http://mnt.to/3vxc
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Gina Selir
I am the author of the Fibromyalgia Natural Program and I am available to answer any question you may have about fibro.
-
Gina Selir
I am the author of the Fibromyalgia Natural Program and I am available to answer any question you may have about fibro.
-
Gina Selir
I am the author of the Fibromyalgia Natural Program and I am available to answer any question you may have about fibro.
Advertisement
